Edwards Lifesciences Corp (NYSE:EW) under-valued by 12%
| Website | https://www.edwards.com |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $56,370,040,832 |
| Beta | 1.038058 |
| Average Volume | $2,707,816 |
| Last Dividend | 0% |
| Price on Jul 29, 2022 | $103.92 |
| Autochartist™ Valuation | $116.67 |
| Conclusion |
12% under-valued |
| Download Report |
